PFBT
ANIP icon

Parkside Financial Bank & Trust’s ANI Pharmaceuticals ANIP Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69K Hold
22
– – ﹤0.01% 2177
2025
Q4 		$1.74K Hold
22
– – ﹤0.01% 2154
2025
Q3 		$2.02K Hold
22
– – ﹤0.01% 2026
2025
Q2 		$1.44K Buy
22
+9
+69% +$586 ﹤0.01% 2113
2025
Q1 		$871 Buy
13
+10
+333% +$597 ﹤0.01% 2162
2024
Q4 		$166 Hold
3
– – ﹤0.01% 2079
2024
Q3 		$179 Hold
3
– – ﹤0.01% 2025
2024
Q2 		$192 Hold
3
– – ﹤0.01% 1949
2024
Q1 		$208 Hold
3
– – ﹤0.01% 1927
2023
Q4 		$166 Sell
3
-31
-91% -$1.71K ﹤0.01% 1976
2023
Q3 		$1.98K Hold
34
– – ﹤0.01% 1667
2023
Q2 		$1.83K Hold
34
– – ﹤0.01% 1715
2023
Q1 		$1.35K Hold
34
– – ﹤0.01% 1789
2022
Q4 		$1.37K Hold
34
– – ﹤0.01% 1779
2022
Q3 		$1K Buy
+34
New +$1.16K ﹤0.01% 1629
2022
Q1 		– Sell
-53
Closed -$2K – 1822
2021
Q4 		$2K Buy
+53
New +$2.28K ﹤0.01% 1568
2021
Q3 		– Sell
-155
Closed -$5K – 1748
2021
Q2 		$5K Buy
+155
New +$5.27K ﹤0.01% 1211
2020
Q4 		– Sell
-28
Closed -$1K – 1597
2020
Q3 		$1K Buy
28
+15
+115% +$447 ﹤0.01% 1275
2020
Q2 		$0 Buy
+13
New +$466 ﹤0.01% 1476
2020
Q1 		– Sell
-8
Closed – – 1420
2019
Q4 		$0 Sell
8
-3
-27% -$199 ﹤0.01% 1580
2019
Q3 		$1K Hold
11
– – ﹤0.01% 1284
2019
Q2 		$1K Buy
11
+5
+83% +$356 ﹤0.01% 1299
2019
Q1 		$0 Hold
6
– – ﹤0.01% 1537
2018
Q4 		$0 Sell
6
-10
-63% -$524 ﹤0.01% 1445
2018
Q3 		$1K Hold
16
– – ﹤0.01% 1201
2018
Q2 		$1K Hold
16
– – ﹤0.01% 1173
2018
Q1 		$1K Buy
16
+10
+167% +$635 ﹤0.01% 1112
2017
Q4 		$0 Hold
6
– – ﹤0.01% 1359
2017
Q3 		$0 Buy
+6
New +$286 ﹤0.01% 1365
2017
Q1 		– Sell
-4
Closed – – 1351
2016
Q4 		$0 Buy
+4
New +$245 ﹤0.01% 1360

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Parkside Financial Bank & Trust's ANIP Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its ANI Pharmaceuticals (ANIP) position steady in Q1 2026 at 22 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2177.

Parkside Financial Bank & Trust first reported a position in ANIP in Q4 2016 and has held it in 30 quarters since. The position peaked at $5K in Q2 2021. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Parkside Financial Bank & Trust held 22 shares of ANI Pharmaceuticals worth $1.69K as of Q1 2026.
  • Parkside Financial Bank & Trust left its ANI Pharmaceuticals share count unchanged in Q1 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2177 holding.
  • Parkside Financial Bank & Trust first reported a position in ANI Pharmaceuticals in Q4 2016 and has held it in 30 quarters since.
  • Parkside Financial Bank & Trust's ANI Pharmaceuticals position peaked at $5K in Q2 2021.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.